Skip to main content

Table 1 Summary of AAM originating from outside the pelvi-perineal region

From: Aggressive angiomyxoma of the liver: a case report and literature review

Author (reference)

Year

Location

Age

Sex

Size (cm)

Immunohistochemical exam

Surgical treatment

Resection margin (mm)

Adjuvant therapy

Disease-free survival (months)

Recurrence

Magalhaes F.TD [2]

1995

Larynx

63

F

2.0

• Negative: S-100

Tumorectomy

Unknown

No

1

Local recurrence

Yamashita Y [3]

2004

Oral floor

8

F

2.0

• Positive: vimentin

• Negative: S-100, CD34

Surgical excision

10

No

24

None

Pai CY [4]

2008

Supraclavicular fossa

48

M

12 × 10

• Positive: vimentin, desmin, muscle-specific actin, ER

• Negative: cytokeratin, S100, PgR

Wide excision after preoperative biopsy

Unknown

No

6

None

Choi YD [5]

2008

Lung

70

F

6.0 × 5.5

• Positive: vimentin, desmin, actin, ER, PgR

• Negative: cytokeratin, S-100, CD34, bcl-2

Thoracoscopic surgery after preoperative needle biopsy

Unknown

No

8

None

Sylvester DC [6]

2010

Larynx

47

M

4.0 × 2.5

• Negative: S-100, desmin, CD34, SMA

Laryngofissure approach excision biopsy and covering tracheostomy

Unknown

No

48

None

Qi S [7]

2015

Liver

50

F

2.0 × 2.0

• Positive: vimentin, CD34, SMA

• Negative: desmin, S-100, Ki-67, EMA, ER, PgR, CD99, CD10, CAM5.2, CK19

Partial hepatectomy

Unknown

No

6

None

Present case

2016

Liver

33

F

8.0 × 7.5

• Positive: vimentin, desmin, CD34, ER, PgR

• Negative: S-100, EMA, CD99, HMB45, CK19

Subsegmentectomy

2

No

10

None

  1. Abbreviations: AAM aggressive angiomyxoma, ER estrogen receptor, F female, M male, PgR progesterone receptor